Skip to main content
Equibles
XRN logo

XRN · Chiron Real Estate Inc. · Metrics

Track XRN — free

Use XRN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research XRN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$28.83 -1.15 (-3.84%)
Russell 2000 member Rebalance outlook locked
Market Cap
$386.21M
Shares
13.24M
Volume · Oct 21 252.03K Avg daily vol (3M) 111.33K

XRN metrics

87 of 126 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$29.98
Market cap
$386.21M

Price action

20 metrics
Price change (1W)
-8.2%
Price change (30D)
-17.2%
Price change (3M)
-20.9%
Price change (6M)
-14.8%
Price change (YTD)
-11.1%
Price change (1Y)
-6.0%
Trailing year
Price change (5Y)
—
52-week high
$38.10
52-week low
$29.65
Change from 52-week high
-21.3%
Change from 52-week low
+1.1%
Annualized volatility
28.3%
Annualized volatility (3M)
22.6%
Beta
0.4
RSI (14D)
19.4
Price vs SMA 50
-15.2%
Price vs SMA 200
-15.6%
Avg volume (3M)
108,740
Relative volume
2.4
Average dollar volume
$3.80M

Company

3 metrics
Sector
Real Estate
Industry
REIT - Healthcare Facilities
Shares outstanding
13.24M

Valuation

14 metrics
P / FFO
7.1×
Company-stated · TTM · reciprocal yield 14.0%
P / AFFO
—
P / E (TTM)
8.1
Trailing earnings · reciprocal yield 12.4%
PEG ratio
—
EV / revenue
2.5×
reciprocal yield 39.7%
EV / EBITDA
—
EV / EBIT
—
P / sales
2.6×
reciprocal yield 38.9%
P / book
0.6
reciprocal yield 166.4%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
5.3
reciprocal yield 19.0%
Earnings yield
15.9%

Historical valuation

8 metrics
P / E historical average (3Y)
56.3×
reciprocal yield 1.8%
P / E historical average (5Y)
66.8×
reciprocal yield 1.5%
EV / revenue historical average (3Y)
3.6×
reciprocal yield 28.0%
EV / revenue historical average (5Y)
3.6×
reciprocal yield 28.0%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
7.7%
Trailing 12 months
Payout ratio
—
Shareholder yield
6.3%
Dividend / share (TTM)
$2.30
Dividend growth YoY
-84.7%
Dividend growth streak
0
Last ex-dividend
2026-10-20

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
40.9%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
$62.73M
Trailing 12 months
Diluted EPS (TTM)
$3.71
FCF margin
—
Effective tax rate
—

Per share

13 metrics
FFO per diluted share
—
AFFO per diluted share
—
Revenue per diluted share (TTM)
$11.53
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$4.75
Operating cash flow per diluted share (TTM)
$5.64
Free cash flow per diluted share (TTM)
$-724.38
Capital expenditures per diluted share (TTM)
$715.53
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.39
Book value per share
$38.52

Growth

11 metrics
Revenue growth YoY
+4.7%
Year over year
Net income growth YoY
+12,255.7%
Revenue (TTM)
$153.43M
Trailing 12 months
EPS growth YoY
-1,616.7%
Shares change YoY
-1.1%
Year over year · fewer shares
Revenue CAGR (3Y)
+2.6%
Revenue CAGR (5Y)
+9.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
9.5%
Return on assets
4.6%
Debt / equity
0.0
Current ratio
0.2
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
0.2
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$7.93M
Latest balance sheet
Cash & equivalents
$10.66M
Total assets
$1.37B
Total debt
$1.15M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$75.11M
Capital expenditures (TTM)
$88.85M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$5.22M
R&D / revenue
—
Stock compensation / revenue
3.4%

Ownership (13F)

9 metrics
13F filers
170
13F filer change QoQ
+8
Institutional ownership
75.5%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
18.6%
Private-fund adviser ownership
18.2%
Active holders' share change QoQ
+16.8%
Holder tenure
3.4
Price vs estimated holder cost
+6.5%

Ownership (registered funds)

1 metrics
Index-fund ownership
21.1%

Short interest

3 metrics
Short interest
7.2%
Latest settlement · 9.4 days to cover
Days to cover
9.4d
Short-squeeze score
59 / 100

Insider activity

2 metrics
Net insider buying (90D)
$2.58M
Insider-sentiment score
96 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1533615 CUSIP 37954A303 13F (30d) 20 filings 20 filers Visit website Investor relations